{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:38:54Z","timestamp":1774535934496,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1212\/con.0000000000000388","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T04:44:26Z","timestamp":1476420266000},"page":"1529-1552","source":"Crossref","is-referenced-by-count":8,"title":["Imaging of Brain Tumors"],"prefix":"10.1212","volume":"22","author":[{"given":"Mirza A.","family":"Baig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo L.","family":"Mechtler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"e_1_3_1_2_2","first-page":"iv1\u2212iv62","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United Stated in 2008-2012","volume":"17","author":"Ostrom QT","year":"2015","unstructured":"Ostrom QT Gittleman H Fulop J CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United Stated in 2008-2012. Neuro Oncol 2015;17(suppl 4):iv1\u2212iv62. doi:10.1093\/neuonc\/nov189.","journal-title":"Neuro Oncol"},{"issue":"4","key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"17","author":"Ostrom QT","year":"2015","unstructured":"Ostrom QT Gittleman H Fulop J CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol 2015;17(suppl 4):iv1\u2013iv66. doi:10.1093\/neuonc\/nov189.","journal-title":"Neuro Oncol"},{"issue":"3","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3171\/jns.2005.103.3.0428","article-title":"Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury","volume":"103","author":"Smith JS","year":"2005","unstructured":"Smith JS Cha S Mayo MC Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg 2005;103(3):428\u2013438.","journal-title":"J Neurosurg"},{"issue":"3","key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.nurt.2009.05.002","article-title":"Neuroimaging in neuro-oncology","volume":"6","author":"Cha S","year":"2009","unstructured":"Cha S. Neuroimaging in neuro-oncology. Neurotherapeutics 2009;6(3):465\u2013477. doi:10.1016\/j.nurt.2009.05.002.","journal-title":"Neurotherapeutics"},{"key":"e_1_3_1_6_2","unstructured":"Howard J. Central Nervous System Tumors. Neurology Video Textbook DVD Chapter 11 Demos Medical 2013."},{"issue":"8","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3174\/ajnr.A1635","article-title":"Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study","volume":"30","author":"Kim HS","year":"2009","unstructured":"Kim HS Jahng GH Ryu CW Kim SY. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 2009;30(8):1574\u20131577. doi:10.3174\/ajnr.A1635.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejrad.2005.04.010","article-title":"Diffusion tensor tractography in patients with cerebral tumors: a helpful technique for neurosurgical planning and postoperative assessment","volume":"56","author":"Yu CS","year":"2005","unstructured":"Yu CS Li KC Xuan Y Diffusion tensor tractography in patients with cerebral tumors: a helpful technique for neurosurgical planning and postoperative assessment. Eur J Radiol 2005;56(2):197\u2013204.","journal-title":"Eur J Radiol"},{"key":"e_1_3_1_9_2","unstructured":"Hornak JP. The basics of MRI. www.cis.rit.edu\/htbooks\/mri\/. Published 2014. Accessed August 5 2016."},{"issue":"5","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant glioma","volume":"9","author":"Brandsma D","year":"2008","unstructured":"Brandsma D Stalpers L Taal W Clinical features, mechanisms, and management of pseudoprogression in malignant glioma. Lancet Oncol 2008;9(5):453\u2013461. doi:10.1016\/S1470-2045(08)70125-6.","journal-title":"Lancet Oncol"},{"issue":"6","key":"e_1_3_1_11_2","first-page":"1081","article-title":"The role of diffusion-weighted imaging in patients with brain tumors","volume":"22","author":"Kono K","year":"2001","unstructured":"Kono K Inoue Y Nakayama K The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22(6):1081\u20131088.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"944","key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1259\/bjr\/25349497","article-title":"Usefulness of diffusion\/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading?","volume":"79","author":"Fan GG","year":"2006","unstructured":"Fan GG Deng QL Wu ZH Guo QY. Usefulness of diffusion\/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 2006;79(944):652\u2013658. doi:10.1259\/bjr\/25349497.","journal-title":"Br J Radiol"},{"issue":"2","key":"e_1_3_1_13_2","first-page":"266","article-title":"Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging","volume":"26","author":"Cha S","year":"2005","unstructured":"Cha S Tihan T Crawford F Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005;26(2):266\u2013273.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000077458","article-title":"Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy","volume":"82","author":"Fountas KN","year":"2004","unstructured":"Fountas KN Kapsalaki EZ Vogel RL Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 2004;82(2\u20133):90\u201397. doi:10.1159\/000077458.","journal-title":"Stereotact Funct Neurosurg"},{"issue":"7","key":"e_1_3_1_15_2","first-page":"1404","article-title":"A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors","volume":"27","author":"Hollingworth W","year":"2006","unstructured":"Hollingworth W Medina LS Lenkinski RE A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 2006;27(7):1404\u20131411.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00002142-200410000-00005","article-title":"Functional MRI in the brain tumor patient","volume":"15","author":"Bogomolny DL","year":"2004","unstructured":"Bogomolny DL Petrovich NM Hou BL Functional MRI in the brain tumor patient. Top Magn Reson Imaging 2004;15(5):325\u2013335.","journal-title":"Top Magn Reson Imaging"},{"issue":"1","key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2301021122","article-title":"Functional MRI imaging versus Wada test for evaluation of language lateralization: cost analysis","volume":"230","author":"Medina LS","year":"2004","unstructured":"Medina LS Aguirre E Bernal B Altman NR. Functional MRI imaging versus Wada test for evaluation of language lateralization: cost analysis. Radiology 2004;230(1):49\u201354. doi:10.1148\/radiol.2301021122.","journal-title":"Radiology"},{"issue":"1","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3174\/ajnr.A4077","article-title":"MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas","volume":"36","author":"Lasocki A","year":"2015","unstructured":"Lasocki A Tsui A Tacey MA MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas. AJNR Am J Neuroradiol 2015;36(1):77\u201383. doi:10.3174\/ajnr.A4077.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/WCO.0b013e3280895d93","article-title":"Neuroimaging in tuberous sclerosis complex","volume":"20","author":"Luat AF","year":"2007","unstructured":"Luat AF Makki M Chugani HT. Neuroimaging in tuberous sclerosis complex. Curr Opin Neurol 2007;20(2):142\u2013150. doi:10.1097\/WCO.0b013e3280895d93.","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3174\/ajnr.A4284","article-title":"Prognostic value of dynamic susceptibility contrast-enhanced and diffusion-weighted MR imaging in patients with glioblastomas","volume":"36","author":"\u00c7oban G","year":"2015","unstructured":"\u00c7oban G Mohan S Kural F Prognostic value of dynamic susceptibility contrast-enhanced and diffusion-weighted MR imaging in patients with glioblastomas. AJNR Am J Neuroradiol 2015;36(7):1247\u20131252. doi:10.3174\/ajnr.A4284.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3171\/2010.2.JNS091010","article-title":"Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults","volume":"113","author":"Chaichana KL","year":"2010","unstructured":"Chaichana KL Kosztowski T Niranjan A Prognostic significance of contrast-enhancing anaplastic astrocytomas in adults. J Neurosurg 2010;113(2):286\u2013292. doi:10.3171\/2010.2.JNS091010.","journal-title":"J Neurosurg"},{"issue":"7","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/neuonc\/nos112","article-title":"Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival","volume":"14","author":"Hu LS","year":"2012","unstructured":"Hu LS Eschbacher JM Heiserman JE Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival. Neuro Oncol 2012;14(7):919\u2013930. doi:10.1093\/neuonc\/nos112.","journal-title":"Neuro Oncol"},{"issue":"1","key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3892\/ol.2011.445","article-title":"Presentation patterns and outcome of gliomatosis cerebri","volume":"3","author":"Rajz GG","year":"2012","unstructured":"Rajz GG Nass D Talianski E Presentation patterns and outcome of gliomatosis cerebri. Oncol Lett 2012;3(1):209\u2013213. doi:10.3892\/ol.2011.445.","journal-title":"Oncol Lett"},{"issue":"21","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1200\/JCO.2011.40.9565","article-title":"Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide","volume":"30","author":"Stuplich M","year":"2012","unstructured":"Stuplich M Hadizadeh DR Kuchelmeister K Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide. J Clin Oncol 2012;30(21):e180\u2013e183. doi:10.1200\/JCO.2011.40.9565.","journal-title":"J Clin Oncol"},{"issue":"4","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.surneu.2008.09.023","article-title":"Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations","volume":"72","author":"Chaski C","year":"2009","unstructured":"Chaski C Neyns B Michotte A Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations. Surg Neurol 2009;72(4):423\u2013428. doi:10.1016\/j.surneu.2008.09.023.","journal-title":"Surg Neurol"},{"issue":"28","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1200\/JCO.2008.19.8721","article-title":"Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma","volume":"27","author":"Friedman HS","year":"2009","unstructured":"Friedman HS Prados MD Wen PY Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 2009;27(28):4733\u20134740. doi:10.1200\/JCO.2008.19.8721.","journal-title":"J Clin Oncol"},{"issue":"6","key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/WCO.0b013e328332363e","article-title":"Pseudoprogression and pseudoresponse in the treatment of gliomas","volume":"22","author":"Brandsma D","year":"2009","unstructured":"Brandsma D van den Bent MJ. Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol 2009;22(6):633\u2013638. doi:10.1097\/WCO.0b013e328332363e.","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen PY","year":"2010","unstructured":"Wen PY Macdonald DR Reardon DA Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28(11):1963\u20131972. doi:10.1200\/JCO.2009.26.3541.","journal-title":"J Clin Oncol"},{"issue":"5","key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin VA","year":"2011","unstructured":"Levin VA Bidaut L Hou P Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 2011;79(5):1487\u20131495. doi:10.1016\/j.ijrobp.2009.12.061.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0305-7372(03)00105-1","article-title":"The management of brain metastases","volume":"29","author":"Patchell RA","year":"2003","unstructured":"Patchell RA. The management of brain metastases. Cancer Treat Rev 2003;29(6):533\u2013540. doi:10.1016\/S0305-7372(03)00105-1.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiol.2322030959","article-title":"Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging","volume":"232","author":"Provenzale JM","year":"2004","unstructured":"Provenzale JM McGraw P Mhatre P Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 2004;232(2):451\u2013460. doi:10.1148\/radiol.2322030959.","journal-title":"Radiology"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/01.wco.0000191514.37498.2b","article-title":"Brain metastases","volume":"18","author":"Norden AD","year":"2005","unstructured":"Norden AD Wen PY Kesari S. Brain metastases. Curr Opin Neurol 2005;18:654\u2013661.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ncl.2013.07.003","article-title":"Smirniotopoulos JG. Neuroimaging of neurocutaneous diseases","volume":"32","author":"Nandigam K","year":"2014","unstructured":"Nandigam K Mechtler LL. Smirniotopoulos JG. Neuroimaging of neurocutaneous diseases. Neurol Clin 2014;32(1):159\u2013192. doi:10.1016\/j.ncl.2013.07.003.","journal-title":"Neurol Clin"},{"issue":"1","key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ncl.2008.09.015","article-title":"Neuroimaging in neuro-oncology","volume":"27","author":"Mechtler L","year":"2009","unstructured":"Mechtler L. Neuroimaging in neuro-oncology. Neurol Clin 2009;27(1):171\u2013201, ix. doi:10.1016\/j.ncl.2008.09.015.","journal-title":"Neurol Clin"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201610000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:09:00Z","timestamp":1752156540000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1212\/CON.0000000000000388"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000388","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}